The upregulated expression of RFC4 and GMPS mediated by DNA copy number alteration is associated with the early diagnosis and immune escape of ESCC based on a bioinformatic analysis.
The upregulated expression of RFC4 and GMPS mediated by DNA copy number alteration is associated with the early diagnosis and immune escape of ESCC based on a bioinformatic analysis.
复制标题
基于生物信息学分析,DNA拷贝数改变介导的RFC4和GMPS表达上调与ESCC的早期诊断和免疫逃逸相关
DOI:
10.18632/aging.203520
复制
发表时间:
2021-09-14
期刊:
影响因子:
--
通讯作者:
Huang BJ
中科院分区:
文献类型:
--
作者:
Wang J;Luo FF;Huang TJ;Mei Y;Peng LX;Qian CN;Huang BJ
Esophageal squamous cell carcinoma (ESCC) is a malignant tumor that commonly occurs worldwide. Usually, Asia, especially China, has a high incidence of esophageal cancer. ESCC often has a poor outcome because of a late diagnosis and lack of effective treatments. To build foundations for the early diagnosis and treatment of ESCC, we used the gene expression datasets GSE20347 and GSE17351 from the GEO database and a private dataset to uncover differentially expressed genes (DEGs) and key genes in ESCC. Notably, we found that replication factor C subunit 4 (RFC4) and guanine monophosphate synthase (GMPS) were upregulated but have been rarely studied in ESCC. In particular, to the best of our knowledge, our study is the first to explore GMPS and ESCC. Furthermore, we found that high levels of RFC4 and GMPS expression may result from an increase in DNA copy number alterations. Furthermore, RFC4 and GMPS were both upregulated in the early stage and early nodal metastases of esophageal carcinoma. The expression of RFC4 was strongly correlated with GMPS. In addition, we explored the relationship between RFC4 and GMPS expression and tumor-infiltrating immune cells (TILs) in esophageal carcinoma. The results showed that the levels of RFC4 and GMPS increased with a decrease in some tumor-infiltrating cells. Upregulated RFC4 and GMPS with high TILs indicate a worse prognosis. In summary, our study shows that RFC4 and GMPS have potential as biomarkers for the early diagnosis of ESCC and may played a crucial role in the process of tumor immunity in ESCC.
登录
查看更多内容
影响因子:
7.3
作者:
Gao J;Aksoy BA;Dogrusoz U;Dresdner G;Gross B;Sumer SO;Sun Y;Jacobsen A;Sinha R;Larsson E;Cerami E;Sander C;Schultz N
通讯作者:
Schultz N
影响因子:
7.7
作者:
Codipilly DC;Qin Y;Dawsey SM;Kisiel J;Topazian M;Ahlquist D;Iyer PG
通讯作者:
Iyer PG
影响因子:
4.7
作者:
Lee, James J.;Natsuizaka, Mitsuteru;Nakagawa, Hiroshi
通讯作者:
Nakagawa, Hiroshi
影响因子:
5.2
作者:
Meng, Ling-Bing;Shan, Meng-Jie;Gong, Tao
通讯作者:
Gong, Tao
影响因子:
12.3
作者:
Li B;Severson E;Pignon JC;Zhao H;Li T;Novak J;Jiang P;Shen H;Aster JC;Rodig S;Signoretti S;Liu JS;Liu XS
通讯作者:
Liu XS